Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sutton

Showing results (241-250 of 290) with videos related to

Pageof 29
Sort By:
Cancer Research|February 11, 1999
Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomasJ Y Kim, M E Sutton, D J Lu, et al.
World Neurosurgery|July 15, 2022
Carole A. Miller, MD: Matriarch of the Ohio State University's Department of NeurosurgeryDaniel S Ikeda, E Antonio Chiocca, Russel R Lonser, et al.
Cell Reports|May 5, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infectionTaylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Mbio|April 14, 2022
Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever VirusMichael P Doyle, Joseph R Genualdi, Adam L Bailey, et al.
Biomolecules|July 29, 2023
Potential Neuroprotective Effects of Dietary Omega-3 Fatty Acids on Stress in Alzheimer's DiseaseKaitlyn B Hartnett, Bradley J Ferguson, Patrick M Hecht, et al.
The Journal of Biological Chemistry|February 2, 2012
Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9Javier Chaparro-Riggers, Hong Liang, Rachel M DeVay, et al.
Frontiers in Cell and Developmental Biology|June 9, 2025
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Nature Biotechnology|March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blockingAndrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinNaveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Pageof 29

Showing results (241-250 of 290) with videos related to

Sort By:
Pageof 29
Cancer Research|February 11, 1999
Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomasJ Y Kim, M E Sutton, D J Lu, et al.
World Neurosurgery|July 15, 2022
Carole A. Miller, MD: Matriarch of the Ohio State University's Department of NeurosurgeryDaniel S Ikeda, E Antonio Chiocca, Russel R Lonser, et al.
Cell Reports|May 5, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infectionTaylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Mbio|April 14, 2022
Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever VirusMichael P Doyle, Joseph R Genualdi, Adam L Bailey, et al.
Biomolecules|July 29, 2023
Potential Neuroprotective Effects of Dietary Omega-3 Fatty Acids on Stress in Alzheimer's DiseaseKaitlyn B Hartnett, Bradley J Ferguson, Patrick M Hecht, et al.
The Journal of Biological Chemistry|February 2, 2012
Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9Javier Chaparro-Riggers, Hong Liang, Rachel M DeVay, et al.
Frontiers in Cell and Developmental Biology|June 9, 2025
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Nature Biotechnology|March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blockingAndrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinNaveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Pageof 29